423013 — New York, New York

423013 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

423013 has participated in 1 clinical trials.

Therapeutic areas: MAC Lung Disease, Treatment Refractory MAC Lung Disease.

Sponsors: AN2 Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 423013?

423013 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 423013 conducted?

423013 has 1 clinical trials on record. Their work covers MAC Lung Disease, Treatment Refractory MAC Lung Disease.

Is 423013 accredited by Crixeo Health?

423013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 423013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.